Company Information
- Type:
- SME
- Country:
- France
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Privately Held
- Global Compact Status:
- Active
- Participant Since
- 22 July 2013 Letter of Commitment
- Next Communication on Progress (COP) due on:
- 31 July 2024
Communication On Progress
| Published On | Title | Level/Status |
|---|---|---|
| 14-Apr-2022 | Communication on Progress 2022 | Active |
| 23-Apr-2021 | Communication on Progress 23 April 2021 | Active |
| 25-Jul-2019 | Communication on Progress | Active |
| 23-Jul-2018 | EFFI-STAT Communication on Progress 2018 | Active |
| 21-Jul-2017 | COP EFFI-STAT 2017 07 21 | Active |
| 22-Jul-2016 | COP EFFI-STAT 2016 07 22 | Active |
| 22-Jul-2015 | Communication on Progress | Active |
| 23-Jul-2014 | Communication on Progress 22JUL2014 updated | Active |
| 22-Jul-2014 | Communication on Progress 22JUL2014 | Learner |
Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.
Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP, for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.